To compare HbA1c and clinical outcomes in adolescents and young adults with type 1 diabetes, with or without celiac disease.
Technology use in type 1 diabetes (T1D) is impacted by socioeconomic status (SES). This analysis explored relationships between SES, glycemic outcomes, and technology use.
Continuous glucose monitoring (CGM) devices have demonstrated efficacy in adults and more recently in youths and older adults with type 1 diabetes. In adults with type 1 diabetes, the use of real-time CGM compared with intermittently scanned CGM was…
Anyone attending a Continuous Glucose Monitoring (CGM) start at PCH recently will have been offered the chance to use our new Virtual Reality googles also known as ‘SmileyScope’.
Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CG…
The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence (the Centre), announces 2023 Round 2, Honours and PhD scholarships for students dedicated to type 1 diabetes (T1D) research.
The innovative new data platform that will provide patients and families, clinicians and researchers with unparalleled access to diabetes-related information and resources is on its way. As the DiabHQ project enters its second year, we reflect on th…
Researcher Spotlight - Dr Aveni Haynes